GlassScriptPhysician profile
Jessica M Cox
NPI 1487184156
$7,262.46
in general payments reported to CMS, 2019-2025
46 companies · $1,538 in 2025
The $1,538 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.22 · 2020: $339 · 2021: $1,444 · 2022: $869 · 2023: $1,545 · 2024: $1,501 · 2025: $1,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,584.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,926.55 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $1,095.46 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $497.25 | 2023-2025 | Caplyta |
| Glaxosmithkline, LLC. | $477.01 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $369.74 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $290.86 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $258.19 | 2020-2025 | Mounjaro, Zepbound, Emgality |
| Biohaven Pharmaceuticals, INC. | $218.76 | 2021 | |
| Axsome Therapeutics, INC. | $186.17 | 2022-2025 | Auvelity |
| Merck Sharp & Dohme LLC | $184.14 | 2020-2024 | Verquvo, Belsomra, Gardasil |
| Biohaven Pharmaceutical Holding Company LTD. | $138.01 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.83 | 2021-2025 | Xifaxan, Trulance |
| Astrazeneca Pharmaceuticals LP | $114.92 | 2020-2025 | Airsupra |
| Amgen INC. | $107.44 | 2021-2023 | Prolia, Evenity |
| Novartis Pharmaceuticals Corporation | $102.57 | 2020-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $102.36 | 2021-2022 | |
| Astellas Pharma US INC | $99.07 | 2021-2024 | Veozah |
| Exact Sciences Corporation | $83.32 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Nestle Healthcare Nutrition INC. | $75.16 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $73.24 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.69 | 2021 | |
| Janssen Pharmaceuticals, INC | $52.67 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.96 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.09 | 2021-2023 | Trintellix |
| Allergan, INC. | $44.68 | 2020 | |
| Corium, LLC | $43.88 | 2023-2024 | Azstarys |
| Lundbeck LLC | $43.57 | 2024-2025 | Rexulti, Vyepti |
| Phathom Pharmaceuticals, INC. | $40.21 | 2025 | Voquezna |
| Sumitomo Pharma America, INC. | $38.87 | 2023-2025 | Gemtesa |
| Inari Medical, INC. | $26.99 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biogen, INC. | $24.13 | 2021 | |
| Inspire Medical Systems, INC. | $23.06 | 2023 | Inspire |
| Myriad Women'S Health, INC. | $21.45 | 2023 | Myrisk |
| Jazz Pharmaceuticals INC. | $21.05 | 2023 | |
| Vifor Pharma, INC. | $21.02 | 2022 | |
| Mylan Specialty L.P. | $20.10 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.12 | 2024 | Camzyos |
| Hologic Sales and Service, LLC | $17.98 | 2024 | Aptima |
| Lifescan, INC. | $17.43 | 2023 | |
| Covis Pharma Gmbh | $16.12 | 2022 | |
| Pulmonx Corporation | $15.84 | 2023 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Harmony Biosciences LLC | $15.71 | 2023 | Wakix |
| Vertex Pharmaceuticals Incorporated | $15.33 | 2025 | |
| Nevro Corp. | $14.91 | 2023 | Senza |
| Endogastric Solutions, INC | $12.45 | 2024 | Esophyx |
| Amneal Pharmaceuticals LLC | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.